glp 1 inhibitors mechanism of action Glucagon-like peptide-1 GLP-1-based therapies for type 2

It helps protect liver cells from oxidative stress

Similar patterns appeared in other obesity-related cancers: Non-small cell lung cancer: progression to Stage IV roughly 10% versus 22% Colorectal cancer: statistically significant reduction in progression Hepatocellular (liver) cancer: signal in the same direction A separate JAMA Oncology study by Dai and colleagues (2025), distinct from the Cleveland Clinic ASCO analysis, found about a 17% lower overall cancer incidence (hazard ratio approximately 0.83) in adults with obesity who used GLP-1 receptor agonists, with most of the signal coming from skin cancers and obesity-related solid tumors

All species upregulate tight junction proteins (Occludin, ZO-1, Claudins) to reduce endotoxin translocation to the liver, though Bifidobacterium and L

Hoppel C

H.R.4818 - Treat and Reduce Obesity Act of 2023